WO1998040082A1 - THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT - Google Patents

THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT Download PDF

Info

Publication number
WO1998040082A1
WO1998040082A1 PCT/EP1998/001202 EP9801202W WO9840082A1 WO 1998040082 A1 WO1998040082 A1 WO 1998040082A1 EP 9801202 W EP9801202 W EP 9801202W WO 9840082 A1 WO9840082 A1 WO 9840082A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucans
soluble
water
use according
production
Prior art date
Application number
PCT/EP1998/001202
Other languages
German (de)
French (fr)
Inventor
Ute Griesbach
Elke Wiemann
Heinz Eggensperger
Original Assignee
Henkel Kommanditgesellschaft Auf Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommanditgesellschaft Auf Aktien filed Critical Henkel Kommanditgesellschaft Auf Aktien
Publication of WO1998040082A1 publication Critical patent/WO1998040082A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the invention relates to the use of water-soluble ß-glucans as active ingredients for combating wrinkles in the skin and skin diseases such as psoriasis, psoriasis or UV erythema.
  • Age-related wrinkling is caused by the breakdown of various macromolecules such as elastin and collagen, for which elastases in the stratum corneum are responsible.
  • a variety of inflammatory skin diseases, such as psoriasis or UV erythema, can also be linked to an increased concentration of elastase in the upper layers of the skin [cf. R. Voegeli et al. in Cosm.Toil. _____, 51 (1996)].
  • cytostatic active ingredients such as selenium sulfide, cadmium sulfide, zinc pyrithione or corticosteroids, are used to combat psoriasis, the medical effect of which is based, for example, on a reduction in mitotic activity in the basal membrane.
  • these substances should not be used for extended periods.
  • psoriasis can be reduced by antiseptic agents, such as selenium oxide, salicylic acid, pyrithione derivatives, hexachlorophene or quaternary ammonium compounds or by cell-dissolving and degreasing agents such as benzoyl peroxide or tar extracts, but do not cure them.
  • antiseptic agents such as selenium oxide, salicylic acid, pyrithione derivatives, hexachlorophene or quaternary ammonium compounds
  • cell-dissolving and degreasing agents such as benzoyl peroxide or tar extracts
  • glucan-containing preparations as antitumor agents is known from German published application DE-OS 2604481 (Ajinomoto).
  • European patent application EP-A1 0463540 (Taito) reports on the use of glucans against viruses. According to the teaching of the two documents DE-A1 3744345 (Lomapharm) and EP-B1 0175667 (noise), glucans are suitable for stimulating macrophage activity.
  • the pharmaceutical effect of various glucans is also known from the two European patent applications EP-A1 0045338 (Debat) and EP-A1 0561408 (Kaken). Finally, soluble phosphorylated glucans are the subject of the European patent EP-B1 0232405 (Tulane Educational Fund).
  • the complex object of the invention was therefore to provide active ingredients which can be used at the same time against wrinkling in the skin (cosmetic effect) and skin diseases (medical effect) and which have a high dermatological and toxicological compatibility.
  • the invention relates to the use of water-soluble ß-glucans as active ingredients for the production of therapeutic agents for skin treatment, in particular for the preparation of agents which simultaneously counteract skin aging and wrinkling and erythema. Thanks to their significant contribution to UV protection, the ß-glucans are particularly suitable for use in sunscreens.
  • water-soluble ⁇ -glucans preferably those obtained by extraction of Basidiomycetes and / or Ascomyceten, in the Langerhans cells of the cause deeper skin layers to have an immune modulation that produces special cytokines.
  • ß-Glucans are also toxicologically safe.
  • glucans is understood to mean homopolysaccharides based on glucose. Depending on the steric linkage, a distinction is made between ß-1, 3-, ß-1,4- and ß-1,6-glucans.
  • ⁇ -1,3-glucans usually have a helical structure, while glucans with a 1,4-linkage generally have a linear structure.
  • the ⁇ -glucans of the invention can be obtained, for example, by extracting higher fungi, such as, for example, the Basidiomycete Schizophyllum Commune or Conolosus versicolor, or by extracting tubular fungi, such as e.g. Prepare ascomycetes of the type Scleroticum glucanium.
  • ⁇ -glucans or their technical mixtures which have a proportion of at least 50, preferably 60 to 100 and in particular 70 to 90% by weight of a ⁇ -1,3 basic structure. It is also advantageous if the glucans have a triple helix fine structure and Molecular weights in the range above 50,000, preferably 100,000 to 1,000,000 daltons. It can also be advantageous to use glucans which have a branch at C-6, preferably with a further saccharide such as, for example, glucose, arabinose or xylose.
  • CM-glucan aqueous or aqueous-alcoholic solutions with an active substance content in the range from 0.1 to 5, preferably 0.5 to 3.
  • the water-soluble ⁇ -glucans can be used as active ingredients for the production of cosmetic and / or pharmaceutical preparations.
  • Typical examples of such agents are skin care products such as anti-wrinkle creams, anti-cellulite creams or sunscreen lotions and ointments for the treatment of skin diseases such as cradle cap, psoriasis, seborrheic dermatitis, seborrhea sicca, seborrhoe oleosa, psoriasis vulgaris, ichthyosis or UV erythema.
  • skin care products such as anti-wrinkle creams, anti-cellulite creams or sunscreen lotions and ointments for the treatment of skin diseases such as cradle cap, psoriasis, seborrheic dermatitis, seborrhea sicca, seborrhoe oleosa, psoriasis vulgaris, ichthyosis or UV erythem
  • the preparations can contain minor amounts of anionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants that are compatible with the other ingredients.
  • anionic surfactants are soaps, alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerin ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, hydroxymixed ether sulfates, fatty ether sulfate monates dialkyl sulfosuccinates, mono- and Dialkylsulfo- succinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and salts thereof, fatty acid
  • anionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, alk (en) yl oligo glycosides, fatty acid N-alkylglucamides, protein hydrolyzates (especially vegetable products based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of cationic surfactants are quaternary ammonium compounds and ester quats, in particular quaternized fatty acid trialkanolamine ester salts.
  • Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • the agents can contain, as further auxiliaries and additives, oil bodies, emulsifiers, superfatting agents, stabilizers, waxes, consistency agents, thickeners, cation polymers, silicone compounds, biogenic active ingredients, antidandruff agents, film formers, preservatives, hydrotropes, solubilizers, UV light protection filters, colorants and fragrances .
  • Guerbet alcohols based on fatty alcohols with 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C2o fatty acids with linear C6-C20 fatty alcohols, esters of branched C6-Ci3-carboxylic acids with linear C6-C20- Fe.talkol.olen, esters of linear C6-Ci8 fatty acids with branched alcohols, especially 2-ethylhexanol, esters of linear and / or branched fatty acids with polyhydric alcohols (such as dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C ⁇ -Cio fatty acids, vegetable oils, branched primary alcohols, substituted cyclo-hexanes, Guerbet carbonates, dialkyl ethers, silicone oils and / or aliphatic or naphthenic hydrocarbons.
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • polystyrene resin e.g. Polyglycerol polyricin oleate or polyglycerol poly-12-hydroxystearate. Mixtures of compounds from several of these classes of substances are also suitable;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters as well as sorbitan mono- and diesters with fatty acids or with castor oil are known, commercially available products. These are mixtures of homologs, the middle of which Degree of alkoxylation corresponds to the ratio of the amounts of substance of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out.
  • C12 /. . -Fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE-PS 20 24 051 as refatting agents for cosmetic preparations.
  • C8 / i8 alkyl mono- and oligoglycosides their preparation and their use as surface-active substances are known, for example, from US 3,839,318, US 3,707,535, US 3,547,828, DE-OS 1943689, DE-OS 2036472 and DE-A1 3001064 and EP-A 0077167. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • the glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable.
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N- dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylamino-propyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylmethyl-3-hydroxyethylimidazolines each with 8 to 18 C-atoms or acyl group in the C-atom group as well as the cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate.
  • betaines such as the N-alkyl-N, N- dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylamino-propyl-N, N-dimethylammonium g
  • fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine is particularly preferred.
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a Cs-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO3H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids, each with about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and Ci2 / ⁇ s-acylsarcosine.
  • quaternary emulsifiers are also suitable, those of the esterquat type, preferably methyl-quaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Substances such as lanolin and lecithin as well as polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • As consistency agents primarily fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms come into consideration. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methyl glucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinylpyrrolidone, surfactants such as, for example ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides as well as electrolytes such as table salt and ammonium chloride.
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers such as, for example, Luviquat® (BASF AG, Ludwigshafen / FRG), condensation products of polyglycols and amines, and quaternized hydroxylated collagen polypeptides hydrolyzed collagen (Lamequat ⁇ L, Grünau GmbH), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as Amidomethicone or Dow Corning, Dow Corning Co./US, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetrimamine (Cartaretine®, Sandoz / CH), polyaminopolyamides as described for example in FR-A 22 52 840 and their crosslinked water-soluble polymers, cationic chitin
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature.
  • Typical examples of fats are glycerides, waxes include Beeswax, paraffin wax or micro waxes, optionally in combination with hydrophilic waxes, e.g. Cetylstearyl alcohol in question.
  • Mono and difatty acid esters of polyalkylene glycols, partial glycerides or esters of fatty alcohols with polyvalent carboxylic acids or hydroxycarboxylic acids can be used in particular as pearlescent waxes.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate can be used.
  • Biogenic active substances are understood to mean, for example, bisabolol, allantoin, phytantriol, panthenol, AHA acids, plant extracts and vitamin complexes.
  • Climbazole, octopirox and zinc pyrethione can be used as antidandruff agents.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Hydrotropes such as ethanol, isopropyl alcohol, propylene glycol or glucose can also be used to improve the flow behavior.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid.
  • UV light protection filters are 4-aminobenzoic acid and its esters and derivatives (e.g. 2-ethylhexyl p-dimethylaminobenzoate or p-dimethylaminobenzoic acid octyl ester), methoxycinnamic acid and its derivatives (e.g. 4-methoxycinnamic acid 2-ethylhexyl ester), benzophenones (e.g.
  • Finely dispersed metal oxides or salts such as titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc) and barium sulfate, are also suitable.
  • secondary light stabilizers of the antioxidant type can also be used, such as superoxide dismutase, tocopherols (vitamin E) and ascorbic acid (vitamin C).
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • O / W skin creams of the following composition were prepared by mixing phases I and II at 95 ° C:
  • Phase I cetylstearyl alcohol 8.0% by weight
  • Phase II glycerin 6.0% by weight ceteareth-12 1.5% by weight glucan * 20.0% by weight ceteareth-20 1.5% by weight %
  • the number, depth and length of the skin folds were determined every 7 days using profilometry of a selected area of skin, namely a vertical stripe 2 cm wide and 5 cm long, the upper left and right boundaries of which result when one draws a horizontal line from the root of the nose, removes 2 or 4 cm from this towards the right eye and extends the two resulting points at an angle of 270 ° each 2 cm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to the use of water-soluble β-glucans as active substances in the production of therapeutic agents in skin treatment. Said agents strengthen the immune system of the skin and counteract wrinkling and can be used to prevent scaling and psoriasis. Said agents can also be used to produce sun-screening agents.

Description

Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur HautbehandlungUse of water-soluble ß-glucans as active ingredients for the production of therapeutic agents for skin treatment
Gebiet der ErfindungField of the Invention
Die Erfindung betrifft die Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Bekämpfung der Faltenbildung in der Haut sowie von Hauterkrankungen wie beispielsweise Schuppenflechte, Psoriasis oder UV-Erythemen.The invention relates to the use of water-soluble ß-glucans as active ingredients for combating wrinkles in the skin and skin diseases such as psoriasis, psoriasis or UV erythema.
Stand der TechnikState of the art
Die altersbedingte Faltenbildung wird durch den Abbau von verschiedenen Makromolekülen wie beispielsweise Elastin und Kollagen hervorgerufen, für den Elastasen im Stratum corneum verantwortlich sind. Auch eine Vielzahl von entzündlichen Hauterkrankungen, wie beispielsweise Schuppenflechte oder UV-Erytheme, lassen sich ursächlich mit einer erhöhten Elastasekonzentration in den oberen Hautschichten in Verbindung bringen [vgl. R.Voegeli et al. in Cosm.Toil. ____, 51 (1996)].Age-related wrinkling is caused by the breakdown of various macromolecules such as elastin and collagen, for which elastases in the stratum corneum are responsible. A variety of inflammatory skin diseases, such as psoriasis or UV erythema, can also be linked to an increased concentration of elastase in the upper layers of the skin [cf. R. Voegeli et al. in Cosm.Toil. ____, 51 (1996)].
Der Faltenbildung in der Haut wird in der Regel nicht durch physiologisch wirksame Prinzipien, sondern durch kosmetische Mittel entgegengewirkt. Viele sogenannte „Antiaging Produkte" enthalten mit Wasser oder wäßrigen Wirkstoffen beladene Liposomen, die durch die Fettschicht der Haut in die Epidermis gelangen, sich dort allmählich auflösen und durch die kontinuierliche Wasserabgabe die Hautvertiefungen füllen und den Feuchtigkeitsgehalt der Haut regulieren. Dieser Effekt stellt jedoch keine Bekämpfung der Ursachen dar, sondern hat lediglich einen sogenannten „repair effect", der zudem nur über eine kurze Zeit andauert.The formation of wrinkles in the skin is usually counteracted not by physiologically effective principles, but by cosmetic means. Many so-called "antiaging products" contain liposomes loaded with water or aqueous active ingredients, which penetrate through the fatty layer of the skin into the epidermis, gradually dissolve there and, due to the continuous release of water, fill the skin depressions and regulate the moisture content of the skin. However, this effect does not result Combat the causes, but only has a so-called "repair effect", which also lasts only for a short time.
Im Gegensatz zu dieser rein kosmetischen Anwendung dienen der Bekämpfung der Schuppenflechte beispielsweise cytostatische Wirkstoffe, wie etwa Selensulfid, Cadmiumsulfid, Zinkpyrithione oder Corti- costeroide, deren medizinische Wirkung z.B. auf einer Reduzierung der Mitoseaktivität in der Basal- membran beruht. Wegen der bekannten Nebenwirkungen sollten diese Stoffe jedoch nicht über längere Zeiträume eingesetzt werden. Weiterhin läßt sich die Schuppenflechte durch antiseptische Wirkstoffe, wie beispielsweise Selenoxid, Salicylsäure, Pyrithionderivate, Hexachlorophen oder quartäre Ammoniumverbindungen bzw. durch zellösende und entfettende Wirkstoffe wie beispielsweise Benzoyl- peroxid oder Teerextrakte lindern, jedoch nicht heilen.In contrast to this purely cosmetic application, cytostatic active ingredients, such as selenium sulfide, cadmium sulfide, zinc pyrithione or corticosteroids, are used to combat psoriasis, the medical effect of which is based, for example, on a reduction in mitotic activity in the basal membrane. However, due to the known side effects, these substances should not be used for extended periods. Furthermore, psoriasis can be reduced by antiseptic agents, such as selenium oxide, salicylic acid, pyrithione derivatives, hexachlorophene or quaternary ammonium compounds or by cell-dissolving and degreasing agents such as benzoyl peroxide or tar extracts, but do not cure them.
Auch die Verwendung von speziellen Polysacchariden als Mittel gegen die Hautalterung ist aus dem Stand der Technik bekannt. So wird beispielsweise in der Patentschrift US 5,223,491 vorgeschlagen, ein carboxymethyliertes ß-1 ,3-Glucan, das aus dem Hefepilz Saccharomyces cerevisiae extrahiert wurde, für die topische Anwendung einzusetzen. Das Glucan ist jedoch wasserunlöslich und kann daher nur mit großen Schwierigkeiten formuliert werden.The use of special polysaccharides as anti-aging agents is also known from the prior art. For example, US Pat. No. 5,223,491 proposes using a carboxymethylated β-1,3-glucan which has been extracted from the yeast fungus Saccharomyces cerevisiae for topical use. However, the glucan is insoluble in water and can therefore only be formulated with great difficulty.
Aus der deutschen Offenlegungsschrift DE-OS 2604481 (Ajinomoto) ist der Einsatz von glucanhaltigen Präparaten als Antitumormittel bekannt. In der europäischen Patentanmeldung EP-A1 0463540 (Taito) wird über den Einsatz von Glucanen gegen Viren berichtet. Gemäß der Lehre der beiden Druckschriften DE-A1 3744345 (Lomapharm) und EP-B1 0175667 (Lärm) eignen sich Glucane zur Stimulation der Makrophagenaktivität. Die pharmazeutische Wirkung verschiedener Glucane ist des weiteren aus den beiden europäischen Patentanmeldungen EP-A1 0045338 (Debat) und EP-A1 0561408 (Ka- ken) bekannt. Lösliche phosphorylierte Glucane sind schließlich Gegenstand der europäischen Patentschrift EP-B1 0232405 (Tulane Educational Fund).The use of glucan-containing preparations as antitumor agents is known from German published application DE-OS 2604481 (Ajinomoto). European patent application EP-A1 0463540 (Taito) reports on the use of glucans against viruses. According to the teaching of the two documents DE-A1 3744345 (Lomapharm) and EP-B1 0175667 (noise), glucans are suitable for stimulating macrophage activity. The pharmaceutical effect of various glucans is also known from the two European patent applications EP-A1 0045338 (Debat) and EP-A1 0561408 (Kaken). Finally, soluble phosphorylated glucans are the subject of the European patent EP-B1 0232405 (Tulane Educational Fund).
Aus dem Stand der Technik sind also für die Glättung der Haut und die Stärkung der Barrierefunktion, sei es aus kosmetischer oder medizinischer Sicht, sehr unterschiedliche Lösungen bekannt, die jeweils aber nur eine Teilaufgabe lösen und zudem noch mit starken Nebenwirkungen verbunden sein können. Die komplexe Aufgabe der Erfindung hat demnach darin bestanden, Wirkstoffe zur Verfügung zu stellen, die gleichzeitig gegen die Faltenbildung in der Haut (kosmetische Wirkung) und Hauterkrankungen (medizinische Wirkung) eingesetzt werden können und dabei eine hohe dermatologische und toxikologische Verträglichkeit besitzen.From the prior art, very different solutions are known for smoothing the skin and strengthening the barrier function, be it from a cosmetic or medical point of view, but they each solve only a subtask and can also be associated with strong side effects. The complex object of the invention was therefore to provide active ingredients which can be used at the same time against wrinkling in the skin (cosmetic effect) and skin diseases (medical effect) and which have a high dermatological and toxicological compatibility.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung ist die Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung, insbesondere zur Herstellung von Mitteln, die gleichzeitig der Hautalterung und Faltenbildung sowie Erythemen entgegenwirken. Durch einen signifikanten Beitrag zum UV-Schutz eignen sich die ß-Glucane vor allem auch für den Einsatz in Sonnenschutzmitteln.The invention relates to the use of water-soluble ß-glucans as active ingredients for the production of therapeutic agents for skin treatment, in particular for the preparation of agents which simultaneously counteract skin aging and wrinkling and erythema. Thanks to their significant contribution to UV protection, the ß-glucans are particularly suitable for use in sunscreens.
Überraschenderweise wurde gefunden, daß wasserlösliche ß-Glucane, vorzugsweise solche, die durch Extraktion von Basidiomyceten und/oder Ascomyceten erhalten werden, in den Langerhans-Zellen der tieferen Hautschichten eine Immunmodulation hervorrufen, durch die spezielle Cytokine produziert werden. ß-Glucane sind zudem toxikologisch unbedenklich.Surprisingly, it was found that water-soluble β-glucans, preferably those obtained by extraction of Basidiomycetes and / or Ascomyceten, in the Langerhans cells of the cause deeper skin layers to have an immune modulation that produces special cytokines. ß-Glucans are also toxicologically safe.
Wasserlösliche ß-GlucaneWater soluble ß-glucans
Unter der Bezeichnung Glucane werden Homopolysaccharide auf Basis der Glucose verstanden. Je nach sterischer Verknüpfung unterscheidet man zwischen ß-1 ,3-, ß-1,4- und ß-1,6-Glucanen. ß-1 ,3- Glucane weisen meist eine helicale Struktur auf, während Glucane mit einer 1 ,4-Verknüpfung im allgemeinen eine lineare Struktur besitzen. Die ß-Glucane der Erfindung lassen sich beispielsweise durch Extraktion höherer Pilze, wie beispielsweise den Basidiomyceten Schizophyllum Commune oder Conolosus versicolor oder durch Extraktion von Schlauchpilzen, wie z.B. Ascomyceten vom Typ Sclero- ticum glucanium herstellen. In diesen Fällen werden technische Gemische von unsubstituierten ß-1,3-, ß-14, und ß-1 ,6-Glucanen erhalten, die über eine ausgezeichnete Wasserlöslichkeit verfügen. Typische Beispiele für geeignete wasserlösliche ß-Glucangemische sind Schizophyllan (I) und Krestin (II).The term glucans is understood to mean homopolysaccharides based on glucose. Depending on the steric linkage, a distinction is made between ß-1, 3-, ß-1,4- and ß-1,6-glucans. β-1,3-glucans usually have a helical structure, while glucans with a 1,4-linkage generally have a linear structure. The β-glucans of the invention can be obtained, for example, by extracting higher fungi, such as, for example, the Basidiomycete Schizophyllum Commune or Conolosus versicolor, or by extracting tubular fungi, such as e.g. Prepare ascomycetes of the type Scleroticum glucanium. In these cases, technical mixtures of unsubstituted ß-1,3-, ß-14, and ß-1, 6-glucans are obtained which have excellent water solubility. Typical examples of suitable water-soluble β-glucan mixtures are schizophyllan (I) and krestin (II).
Figure imgf000005_0001
Figure imgf000005_0001
Figure imgf000005_0002
Figure imgf000005_0002
Besonders bevorzugt ist der Einsatz von ß-Glucanen bzw. deren technischen Gemischen, die einen Anteil von mindestens 50, vorzugsweise 60 bis 100 und insbesondere 70 bis 90 Gew.-% einer ß-1,3- Grundstruktur aufweisen. Weiterhin vorteilhaft ist, wenn die Glucane eine Tripelhelix-Feinstruktur und Molekulargewichte im Bereich oberhalb von 50.000, vorzugsweise 100.000 bis 1.000.000 Dalton besitzen. Weiterhin vorteilhaft kann es sein, wenn man Glucane einsetzt, die am C-6 eine Verzweigung, vorzugsweise mit einem weiteren Saccharid wie beispielsweise Glucose, Arabinose oder Xylose aufweisen.It is particularly preferred to use β-glucans or their technical mixtures which have a proportion of at least 50, preferably 60 to 100 and in particular 70 to 90% by weight of a β-1,3 basic structure. It is also advantageous if the glucans have a triple helix fine structure and Molecular weights in the range above 50,000, preferably 100,000 to 1,000,000 daltons. It can also be advantageous to use glucans which have a branch at C-6, preferably with a further saccharide such as, for example, glucose, arabinose or xylose.
Die Extraktion der Pilze kann in an sich bekannter Weise nach den Verfahren des Stands der Technik erfolgen und verlangt vom Fachmann nicht erfinderisch tätig zu werden, zumal beispielsweise Extrakte auf Basis verschiedener Hefepilze unter der Bezeichnung „CM-Glucan" im Handel erhältlich sind. Üblicherweise werden die Extrakte als wäßrige oder wäßrig-alkoholische Lösungen mit einem Aktivsubstanzgehalt im Bereich von 0,1 bis 5, vorzugsweise 0,5 bis 3 eingesetzt.The extraction of the mushrooms can be carried out in a manner known per se by the methods of the prior art and does not require the person skilled in the art to be inventive, especially since extracts based on various yeasts are commercially available under the name “CM-glucan” the extracts are used as aqueous or aqueous-alcoholic solutions with an active substance content in the range from 0.1 to 5, preferably 0.5 to 3.
Gewerbliche AnwendbarkeitIndustrial applicability
Im Sinne der Erfindung können die wasserlöslichen ß-Glucane als Wirkstoffe zur Herstellung von kosmetischen und/oder pharmazeutischen Zubereitungen eingesetzt werden. Typische Beispiele für solche Mittel sind Hautpflegemittel wie beispielsweise Antifaltencremes, Anticellulitiscremes oder Sonnenschutzlotionen sowie Salben zur Behandlung von Hauterkrankungen wie beispielsweise Cradle Cap, Schuppenflechte, Seborrhoische Dermatitis, Seborrhoe Sicca, Seborrhoe Oleosa, Psoriasis vulgaris, Ichtyosen oder UV-Erythemen. Üblicherweise können die wasserlöslichen ß-Glucane inFor the purposes of the invention, the water-soluble β-glucans can be used as active ingredients for the production of cosmetic and / or pharmaceutical preparations. Typical examples of such agents are skin care products such as anti-wrinkle creams, anti-cellulite creams or sunscreen lotions and ointments for the treatment of skin diseases such as cradle cap, psoriasis, seborrheic dermatitis, seborrhea sicca, seborrhoe oleosa, psoriasis vulgaris, ichthyosis or UV erythema. Usually the water-soluble ß-glucans in
Mengen von 0,0001 bis 5, vorzugsweise 0,001 bis 1 und insbesondere 0,01 bis 0,1 Gew.-% - bezogen auf die Mittel - eingesetzt werden.Amounts of 0.0001 to 5, preferably 0.001 to 1 and in particular 0.01 to 0.1% by weight, based on the composition, are used.
Die Zubereitungen können in untergeordneten Mengen mit den anderen Inhaltsstoffen kompatible anionische, nichtionische, kationische und/oder amphotere bzw. zwitterionische Tenside enthalten. Typische Beispiele für anionische Tenside sind Seifen, Alkylbenzolsulfonate, Alkansulfonate, Olefinsulfonate, Alkylethersulfonate, Glycerinethersulfonate, α-Methyl-estersulfonate, Sulfofettsäuren, Alkylsulfate, Fettalkoholethersulfate, Glycerinethersulfate, Hydroxymischethersulfate, Monoglycerid- (ether)sulfate, Fettsäureamid(ether)sulfate, Mono- und Dialkylsulfosuccinate, Mono- und Dialkylsulfo- succinamate, Sulfotriglyceride, Amidseifen, Ethercarbonsäuren und deren Salze, Fettsäureisethionate, Fettsäuresarcosinate, Fettsäuretauride, N-Acylaminosäuren wie beispielsweise Acyllactylate, Acyl- tartrate, Acylglutamate und Acylaspartate, Alkyloligoglucosidsulfate, Proteinfettsäurekondensate (insbesondere pflanzliche Produkte auf Weizenbasis) und Alkyl(ether)phosphate. Sofern die anionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für nichtionische Tenside sind Fett- alkoholpolyglycolether, Alkylphenolpolyglycolether, Fettsäurepolyglycolester, Fettsäureamidpolyglycol- ether, Fettaminpolyglycolether, alkoxylierte Triglyceride, Mischether bzw. Mischformale, Alk(en)yloligo- glykoside, Fettsäure-N-alkylglucamide, Proteinhydrolysate (insbesondere pflanzliche Produkte auf Weizenbasis), Polyolfettsaureester, Zuckerester, Sorbitanester, Polysorbate und Aminoxide. Sofern die nichtionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für kationische Tenside sind quartäre Ammoniumverbindungen und Esterquats, insbesondere quaternierte Fettsäu- retrialkanolaminestersalze. Typische Beispiele für amphotere bzw. zwitterionische Tenside sind Alkylbetaine, Alkylamidobetaine, Aminopropionate, Aminoglycinate, Imidazoliniumbetaine und Sulfo- betaine. Bei den genannten Tensiden handelt es sich ausschließlich um bekannte Verbindungen. Hinsichtlich Struktur und Herstellung dieser Stoffe sei auf einschlägige Übersichtsarbeiten beispielsweise J.Falbe (ed.), "Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, S. 54-124 oder J.Falbe (ed.), "Katalysatoren, Tenside und Mineralöladditive", Thieme Verlag, Stuttgart, 1978, S. 123-217 verwiesen.The preparations can contain minor amounts of anionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants that are compatible with the other ingredients. Typical examples of anionic surfactants are soaps, alkylbenzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerin ether sulfonates, α-methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether sulfates, hydroxymixed ether sulfates, fatty ether sulfate monates dialkyl sulfosuccinates, mono- and Dialkylsulfo- succinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and salts thereof, fatty acid taurides, N-acylamino acids such as acyl lactylates, acyl tartrates, acyl glutamates and acyl aspartates, alkyl oligoglucoside sulfates, protein fatty acid condensates (in particular vegetable products based on wheat) and Alkyl (ether) phosphates. If the anionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, alk (en) yl oligo glycosides, fatty acid N-alkylglucamides, protein hydrolyzates (especially vegetable products based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides. If the nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of cationic surfactants are quaternary ammonium compounds and ester quats, in particular quaternized fatty acid trialkanolamine ester salts. Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds. With regard to the structure and manufacture of these substances, reference is made to relevant reviews, for example J.Falbe (ed.), "Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, pp. 54-124 or J.Falbe (ed.), "Catalysts, Surfactants and mineral oil additives ", Thieme Verlag, Stuttgart, 1978, pp. 123-217.
Ferner können die Mittel als weitere Hilfs- und Zusatzstoffe Ölkörper, Emulgatoren, Überfettungsmittel, Stabilisatoren, Wachse, Konsistenzgeber, Verdickungsmittel, Kationpolymere, Siliconverbindungen, biogene Wirkstoffe, Antischuppenmittel, Filmbildner, Konservierungsmittel, Hydrotrope, Solubilisatoren, UV-Lichtschutzfilter, Färb- und Duftstoffe enthalten.Furthermore, the agents can contain, as further auxiliaries and additives, oil bodies, emulsifiers, superfatting agents, stabilizers, waxes, consistency agents, thickeners, cation polymers, silicone compounds, biogenic active ingredients, antidandruff agents, film formers, preservatives, hydrotropes, solubilizers, UV light protection filters, colorants and fragrances .
Als Ölkörper kommen beispielsweise Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 Kohlenstoffatomen, Ester von linearen C6-C2o-Fettsäuren mit linearen C6-C20- Fettalkoholen, Ester von verzweigten C6-Ci3-Carbonsäuren mit linearen C6-C20-Fe.talkol.olen, Ester von linearen C6-Ci8-Fettsäuren mit verzweigten Alkoholen, insbesondere 2-Ethylhexanol, Ester von linearen und/oder verzweigten Fettsäuren mit mehrwertigen Alkoholen (wie z.B. Dimerdiol oder Trimertriol) und/oder Guerbetalkoholen, Triglyceride auf Basis Cθ-Cio-Fettsäuren, pflanzliche Öle, verzweigte primäre Alkohole, substituierte Cyclo-hexane, Guerbetcarbonate, Dialkylether, Siliconöle und/oder aliphatische bzw. naphthenische Kohlenwasserstoffe in Betracht.Guerbet alcohols based on fatty alcohols with 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C2o fatty acids with linear C6-C20 fatty alcohols, esters of branched C6-Ci3-carboxylic acids with linear C6-C20- Fe.talkol.olen, esters of linear C6-Ci8 fatty acids with branched alcohols, especially 2-ethylhexanol, esters of linear and / or branched fatty acids with polyhydric alcohols (such as dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on Cθ -Cio fatty acids, vegetable oils, branched primary alcohols, substituted cyclo-hexanes, Guerbet carbonates, dialkyl ethers, silicone oils and / or aliphatic or naphthenic hydrocarbons.
Als Emulgatoren kommen beispielsweise nichtionogene Tenside aus mindestens einer der folgenden Gruppen in Frage:Examples of suitable emulsifiers are nonionic surfactants from at least one of the following groups:
(1) Anlagerungsprodukte von 2 bis 30 Mol Ethyienoxid und/ oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen und an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe;(1) Addition products of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide with linear fatty alcohols with 8 to 22 C atoms, with fatty acids with 12 to 22 C atoms and with alkylphenols with 8 to 15 C atoms in the Alkyl group;
(2) Ci2/i8-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethyienoxid an Glycerin;(2) Ci2 / i8 fatty acid monoesters and diesters of adducts of 1 to 30 moles of ethylene oxide with glycerol;
(3) Glycerinmono- und -diester und Sorbitanmono- und -diester von gesättigten und ungesättigten Fettsäuren mit 6 bis 22 Kohlenstoffatomen und deren Ethylenoxid-anlagerungsprodukte; (4) Alkylmono- und -oligoglycoside mit 8 bis 22 Kohlenstoffatomen im Alkylrest und deren ethoxy- lierte Analoga;(3) glycerol monoesters and diesters and sorbitan monoesters and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and their ethylene oxide addition products; (4) alkyl mono- and oligoglycosides with 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs;
(5) Anlagerungsprodukte von 15 bis 60 Mol Ethyienoxid an Ricinusöl und/oder gehärtetes Ricinusöl;(5) adducts of 15 to 60 moles of ethylene oxide with castor oil and / or hardened castor oil;
(6) Polyol- und insbesondere Polyglycerinester wie z.B. Polyglycerinpolyricinoleat oder Polyglycerinpoly-12-hydroxystearat. Ebenfalls geeignet sind Gemische von Verbindungen aus mehreren dieser Substanzklassen;(6) polyol and especially polyglycerol esters such as e.g. Polyglycerol polyricin oleate or polyglycerol poly-12-hydroxystearate. Mixtures of compounds from several of these classes of substances are also suitable;
(7) Anlagerungsprodukte von 2 bis 15 Mol Ethyienoxid an Ricinusöl und/oder gehärtetes Ricinusöl;(7) adducts of 2 to 15 moles of ethylene oxide with castor oil and / or hardened castor oil;
(8) Partialester auf Basis linearer, verzweigter, ungesättigter bzw. gesättigter Ci2/22-Fettsäuren, Ricinolsäure sowie 12-Hydroxystearinsäure und Glycerin, Polyglycerin, Pentaerythrit, Dipenta- erythrit, Zuckeralkohole (z.B. Sorbit) sowie Polyglucoside (z.B. Cellulose);(8) partial esters based on linear, branched, unsaturated or saturated Ci2 / 22 fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerin, polyglycerin, pentaerythritol, dipentaerythritol, sugar alcohols (e.g. sorbitol) and polyglucosides (e.g. cellulose);
(9) Trialkylphosphate;(9) trialkyl phosphates;
(10) Wollwachsalkohole;(10) wool wax alcohols;
(11 ) Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;(11) polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives;
(12) Mischester aus Pentaerythrit, Fettsäuren, Citronensaure und Fettalkohol gemäß DE-PS 11 65 574 sowie(12) mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE-PS 11 65 574 and
(13) Polyalkylenglycole.(13) Polyalkylene glycols.
Die Anlagerungsprodukte von Ethyienoxid und/oder von Propylenoxid an Fettalkohole, Fettsäuren, Alkylphenole, Glycerinmono- und -diester sowie Sorbitanmono- und -diester von Fettsäuren oder an Ricinusöl stellen bekannte, im Handel erhältliche Produkte dar. Es handelt sich dabei um Homologengemische, deren mittlerer Alkoxylierungsgrad dem Verhältnis der Stoffmengen von Ethyienoxid und/oder Propylenoxid und Substrat, mit denen die Anlagerungsreaktion durchgeführt wird, entspricht. C12/ ..-Fettsäuremono- und -diester von Anlagerungsprodukten von Ethyienoxid an Glycerin sind aus DE-PS 20 24 051 als Rückfettungsmittel für kosmetische Zubereitungen bekannt.The adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters as well as sorbitan mono- and diesters with fatty acids or with castor oil are known, commercially available products. These are mixtures of homologs, the middle of which Degree of alkoxylation corresponds to the ratio of the amounts of substance of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out. C12 /. . -Fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE-PS 20 24 051 as refatting agents for cosmetic preparations.
C8/i8-Alkylmono- und oligoglycoside, ihre Herstellung und ihre Verwendung als oberflächenaktive Stoffe sind beispielsweise aus US 3,839,318, US 3,707,535, US 3,547,828, DE-OS 1943689, DE-OS 2036472 und DE-A1 3001064 sowie EP-A 0077167 bekannt. Ihre Herstellung erfolgt insbesondere durch Umsetzung von Glucose oder Oligosacchariden mit primären Alkoholen mit 8 bis 18 C-Atomen. Bezüglich des Glycosidrestes gilt, daß sowohl Monoglycoside, bei denen ein cyclischer Zuckerrest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Glycoside mit einem Oligomerisa- tionsgrad bis vorzugsweise etwa 8 geeignet sind. Der Oligomerisierungsgrad ist dabei ein statistischer Mittelwert, dem eine für solche technischen Produkte übliche Homologenverteilung zugrunde liegt.C8 / i8 alkyl mono- and oligoglycosides, their preparation and their use as surface-active substances are known, for example, from US 3,839,318, US 3,707,535, US 3,547,828, DE-OS 1943689, DE-OS 2036472 and DE-A1 3001064 and EP-A 0077167. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms. With regard to the glycoside residue, both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable. The degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
Weiterhin können als Emulgatoren zwitterionische Tenside verwendet werden. Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine Carboxylat- und eine Sulfonatgruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N- dimethylammoniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acylamino- propyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosacylaminopropyldimethylammo- niumglycinat, und 2-Alkyl-3-carboxylmethyl-3-hydroxyethylimidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. Besonders bevorzugt ist das unter der CTFA-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid- Derivat. Ebenfalls geeignete Emulgatoren sind ampholytische Tenside. Unter ampholytischen Tensiden werden solche oberflächenaktiven Verbindungen verstanden, die außer einer Cs -Alkyl- oder -Acylgruppe im Molekül mindestens eine freie Aminogruppe und mindestens eine -COOH- oder -SO3H- Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylpropionsäuren, N-Alkylaminobuttersäuren, N-Alkyliminodi- propionsäuren, N-Hydroxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkyl- aminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 18 C-Atomen in der Alkyl- gruppe. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropionat und das Ci2/ιs-Acylsarcosin. Neben den ampholytischen kommen auch quartäre Emulgatoren in Betracht, wobei solche vom Typ der Esterquats, vorzugsweise methyl- quaternierte Difettsäuretriethanolaminester-Salze, besonders bevorzugt sind.Zwitterionic surfactants can also be used as emulsifiers. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N- dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylamino-propyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylmethyl-3-hydroxyethylimidazolines each with 8 to 18 C-atoms or acyl group in the C-atom group as well as the cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate. The fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine is particularly preferred. Suitable emulsifiers are ampholytic surfactants. Ampholytic surfactants are surface-active compounds which, in addition to a Cs-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SO3H group in the molecule and are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids, each with about 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and Ci2 / ιs-acylsarcosine. In addition to the ampholytic emulsifiers, quaternary emulsifiers are also suitable, those of the esterquat type, preferably methyl-quaternized difatty acid triethanolamine ester salts, being particularly preferred.
Als Überfettungsmittel können Substanzen wie beispielsweise Lanolin und Lecithin sowie polyethoxylierte oder acylierte Lanolin- und Lecithinderivate, Polyolfettsaureester, Monoglyceride und Fettsäurealkanolamide verwendet werden, wobei die letzteren gleichzeitig als Schaumstabilisatoren dienen. Als Konsistenzgeber kommen in erster Linie Fettalkohole mit 12 bis 22 und vorzugsweise 16 bis 18 Kohlenstoffatomen in Betracht. Bevorzugt ist eine Kombination dieser Stoffe mit Alkyloligo- glucosiden und/oder Fettsäure-N-methylglucamiden gleicher Kettenlänge und/oder Polyglycerinpoly-12- hydroxystearaten. Geeignete Verdickungsmittel sind beispielsweise Polysaccharide, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Alginate und Tylosen, Carboxymethylcellulose und Hydroxy- ethylcellulose, ferner höhermolekulare Polyethylenglycolmono- und -diester von Fettsäuren, Polyacry- late, Polyvinylalkohol und Polyvinylpyrrolidon, Tenside wie beispielsweise ethoxylierte Fettsäuregly- ceride, Ester von Fettsäuren mit Polyolen wie beispielsweise Pentaerythrit oder Trimethylolpropan, Fettalkoholethoxylate mit eingeengter Homologenverteilung oder Alkyloligoglucoside sowie Elektrolyte wie Kochsalz und Ammoniumchlorid.Substances such as lanolin and lecithin as well as polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers. As consistency agents, primarily fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms come into consideration. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methyl glucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred. Suitable thickeners are, for example, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinylpyrrolidone, surfactants such as, for example ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides as well as electrolytes such as table salt and ammonium chloride.
Geeignete kationische Polymere sind beispielsweise kationische Cellulosederivate, kationische Stärke, Copolymere von Diallylammoniumsalzen und Acrylamiden, quaternierte Vinylpyrrolidon/ Vinyl- imidazol-Polymere wie z.B. Luviquat® (BASF AG, Ludwigshafen/ FRG), Kondensationsprodukte von Polyglycolen und Aminen, quaternierte Kollagenpolypeptide wie beispielsweise Lauryldimonium hydroxypropyl hydrolyzed collagen (LamequatΘL, Grünau GmbH), quaternierte Weizenpolypeptide, Polyethylenimin, kationische Siliconpolymere wie z.B. Amidomethicone oder Dow Corning, Dow Corning Co./US, Copolymere der Adipinsäure und Dimethylaminohydroxypropyldiethylentrimamin (Cartaretine®, Sandoz/CH), Polyaminopolyamide wie z.B. beschrieben in der FR-A 22 52 840 sowie deren vernetzte wasserlöslichen Polymere, kationische Chitinderivate wie beispielsweise quaterniertes Chitosan, gegebenenfalls mikrokristallin verteilt, Kondensationsprodukte aus Dihalogenalkylen wie z.B. Dibrombutan mit Bisdialkylaminen wie z.B. Bis-Dimethylamino-1 ,3-propan, kationischer Guar-Gum wie z.B. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 der Celanese/US, quaternierte Ammoniumsalz- Polymere wie z.B. Mirapol® A-15, Mirapol® AD-1 , Mirapol® AZ-1 der Miranol/US.Suitable cationic polymers are, for example, cationic cellulose derivatives, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers such as, for example, Luviquat® (BASF AG, Ludwigshafen / FRG), condensation products of polyglycols and amines, and quaternized hydroxylated collagen polypeptides hydrolyzed collagen (LamequatΘL, Grünau GmbH), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as Amidomethicone or Dow Corning, Dow Corning Co./US, copolymers of adipic acid and dimethylaminohydroxypropyldiethylenetrimamine (Cartaretine®, Sandoz / CH), polyaminopolyamides as described for example in FR-A 22 52 840 and their crosslinked water-soluble polymers, cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline, condensation products from dihaloalkylene such as dibromobutane with bisdialkylamines such as bis- Dimethylamino-1, 3-propane, cationic guar gum such as Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese / US, quaternized ammonium salt polymers such as Mirapol® A-15, Mirapol® AD- 1, Mirapol® AZ-1 from Miranol / US.
Geeignete Siliconverbindungen sind beispielsweise Dimethylpolysiloxane, Methyl-phenylpolysiloxane, cyclische Silicone sowie amino-, fettsäure-, alkohol-, polyether-, epoxy-, fluor- und/oder alkylmodifizierte Siliconverbindungen, die bei Raumtemperatur sowohl flüssig als auch harzförmig vorliegen können. Typische Beispiele für Fette sind Glyceride, als Wachse kommen u.a. Bienenwachs, Paraffinwachs oder Mikrowachse gegebenenfalls in Kombination mit hydrophilen Wachsen, z.B. Cetylstearylalkohol in Frage. Als Perlglanzwachse können insbesondere Mono- und Difettsäureester von Polyalkylen- glycolen, Partialglyceride oder Ester von Fettalkoholen mit mehrwertigen Carbonsäuren bzw. Hydroxycarbonsäuren verwendet werden. Als Stabilisatoren können Metallsalze von Fettsäuren wie z.B. Magnesium-, Aluminium- und/oder Zinkstearat eingesetzt werden. Unter biogenen Wirkstoffen sind beispielsweise Bisabolol, Allantoin, Phytantriol, Panthenol, AHA-Säuren, Pflanzenextrakte und Vitaminkomplexe zu verstehen. Als Antischuppenmittel können Climbazol, Octopirox und Zink- pyrethion eingesetzt werden. Gebräuchliche Filmbildner sind beispielsweise Chitosan, mikrokristallines Chitosan, quaterniertes Chitosan, Polyvinylpyrrolidon, Vinylpyrrolidon-Vinylacetat-Copolymerisate, Polymere der Acrylsäurereihe, quaternäre Cellulose-Derivate, Kollagen, Hyaluronsäure bzw. deren Salze und ähnliche Verbindungen. Zur Verbesserung des Fließverhaltens können ferner Hydrotrope wie beispielsweise Ethanol, Isopropylalkohol, Propylenglycol oder Glucose eingesetzt werden. Als Konservierungsmittel eignen sich beispielsweise Phenoxyethanol, Formaldehydlösung, Parabene, Pentandiol oder Sorbinsäure.Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature. Typical examples of fats are glycerides, waxes include Beeswax, paraffin wax or micro waxes, optionally in combination with hydrophilic waxes, e.g. Cetylstearyl alcohol in question. Mono and difatty acid esters of polyalkylene glycols, partial glycerides or esters of fatty alcohols with polyvalent carboxylic acids or hydroxycarboxylic acids can be used in particular as pearlescent waxes. Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate can be used. Biogenic active substances are understood to mean, for example, bisabolol, allantoin, phytantriol, panthenol, AHA acids, plant extracts and vitamin complexes. Climbazole, octopirox and zinc pyrethione can be used as antidandruff agents. Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds. Hydrotropes such as ethanol, isopropyl alcohol, propylene glycol or glucose can also be used to improve the flow behavior. Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid.
Typische Beispiele für UV-Lichtschutzfilter sind 4-Aminobenzoesäure sowie ihre Ester und Derivate (z.B. 2-Ethylhexyl-p-dimethylaminobenzoat oder p-Dimethylaminobenzoesäureoctylester), Methoxy- zimtsäure und ihre Derivate (z.B. 4-Methoxyzimtsäure-2-ethylhexylester), Benzophenone (z.B. Oxyben- zon, 2-Hydroxy-4-methoxy-benzophenon), Dibenzoylmethane, Salicylatester, 2-Phenylbenzimadozol- 5-sulfonsäure, 1-(4-tert.Butylphenyl)-3-(4'-methoxyphenyl)-propan-1 ,3-dion, 3-(4'-Methyl)benzyliden- bornan-2-on, Methyl-benzylidencampher und dergleichen. Weiterhin geeignet sind auch feindisperse Metalloxide bzw. Salze, wie beispielsweise Titandioxid, Zinkoxid, Eisenoxid, Aluminiumoxid, Ceroxid, Zirkoniumoxid, Silicate (Talk) und Bariumsulfat. Schließlich kommen auch sekundäre Lichtschutzmittel vom Typ der Antioxidantien in Betracht, wie etwa Superoxid-Dismutase, Tocopherole (Vitamin E) und Ascorbinsäure (Vitamin C). Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden, wie sie beispielsweise in der Publikation "Kosmetische Färbemittel" der Farbstoffkommission der Deutschen Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, S.81-106 zusammengestellt sind. Diese Farbstoffe werden üblicherweise in Konzentrationen von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, eingesetzt.Typical examples of UV light protection filters are 4-aminobenzoic acid and its esters and derivatives (e.g. 2-ethylhexyl p-dimethylaminobenzoate or p-dimethylaminobenzoic acid octyl ester), methoxycinnamic acid and its derivatives (e.g. 4-methoxycinnamic acid 2-ethylhexyl ester), benzophenones (e.g. Oxybenzone, 2-hydroxy-4-methoxy-benzophenone), dibenzoylmethane, salicylate ester, 2-phenylbenzimadozole-5-sulfonic acid, 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1, 3-dione, 3- (4'-methyl) benzylidene-bornan-2-one, methyl-benzylidene camphor and the like. Finely dispersed metal oxides or salts, such as titanium dioxide, zinc oxide, iron oxide, aluminum oxide, cerium oxide, zirconium oxide, silicates (talc) and barium sulfate, are also suitable. Finally, secondary light stabilizers of the antioxidant type can also be used, such as superoxide dismutase, tocopherols (vitamin E) and ascorbic acid (vitamin C). The dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes" by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
Der Gesamtanteil der Hilfs- und Zusatzstoffe kann 1 bis 50, vorzugsweise 5 bis 40 Gew.-% - bezogen auf die Mittel - betragen. Die Herstellung der Mittel kann durch übliche Kalt- oder Heißprozesse erfolgen; vorzugsweise arbeitet man nach der Phaseninversionstemperatur-Methode. The total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition. The agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
BeispieleExamples
Ein Panel bestehend aus 15 weiblichen Probanden im Alter zwischen 35 und 50 Jahren wurde über einen Zeitraum von 28 Tagen einer täglichen Exposition mit verschiedenen Glucanen ausgesetzt. Hierzu wurden O/W-Hautcremes der folgenden Zusammensetzung durch Vermischen der Phasen I und II bei 95°C hergestellt:A panel consisting of 15 female volunteers between the ages of 35 and 50 years was exposed to a daily exposure to various glucans over a period of 28 days. For this purpose, O / W skin creams of the following composition were prepared by mixing phases I and II at 95 ° C:
Phase I : Cetylstearylalkohol 8,0 Gew.-% Phase II : Glycerin 6,0 Gew.-% Ceteareth-12 1 ,5 Gew.-% Glucan* 20,0 Gew.-% Ceteareth-20 1 ,5 Gew.-% Wasser 38,0 Gew.-% Cetearyl Isononanoate 15,0 Gew.-% Paraffinöl, dickflüssig 5,0 Gew.-% Baysilonöl M 300 5,0 Gew.-% *) 1 Gew.-% AS in WasserPhase I: cetylstearyl alcohol 8.0% by weight Phase II: glycerin 6.0% by weight ceteareth-12 1.5% by weight glucan * 20.0% by weight ceteareth-20 1.5% by weight % Water 38.0% by weight cetearyl isononanoate 15.0% by weight paraffin oil, viscous 5.0% by weight Baysilonöl M 300 5.0% by weight *) 1% by weight AS in water
36,0 Gew.-% : 64,0 Gew.-%36.0% by weight: 64.0% by weight
Die Probanden wendeten die Hautcremes täglich vor dem Zubettgehen an. Im Abstand von 7 Tagen wurde jeweils am darauffolgenden Morgen die Zahl, Tiefe und Länge der Hautfalten mittels Profilome- trie einer ausgesuchten Hautpartie bestimmt, nämlich eines vertikalen Streifens von 2 cm Breite und 5 cm Länge, dessen obere linke und rechte Begrenzung sich ergibt, wenn man von der Nasenwurzel eine Horizontale zieht, von dieser zum rechten Auge hin 2 bzw. 4 cm abträgt und die beiden resultierenden Punkte im Winkel von 270° jeweils 2 cm verlängert. Das dimensionslose Produkt aus Tiefe, Anzahl und Länge der Hautfalten am Tage vor dem Beginn der Exposition wurde als Standard (= 100 %) gesetzt und alle folgenden Messungen darauf bezogen. Gleichzeitig wurde die Hautrauhigkeit von den Probanden subjektiv auf einer Skala von 0 = „unverändert" bis 3 = „stark verbessert" bewertet. Die Ergebnisse sind in Tabelle 1 zusammengefaßt. Die Beispiele 1 bis 3 sind erfindungsgemäß, die Beispiele V1 bis V4 dienen zum Vergleich.The subjects applied the skin creams daily before going to bed. The following morning, the number, depth and length of the skin folds were determined every 7 days using profilometry of a selected area of skin, namely a vertical stripe 2 cm wide and 5 cm long, the upper left and right boundaries of which result when one draws a horizontal line from the root of the nose, removes 2 or 4 cm from this towards the right eye and extends the two resulting points at an angle of 270 ° each 2 cm. The dimensionless product of the depth, number and length of the skin folds on the day before the start of exposure was set as the standard (= 100%) and all subsequent measurements were based on it. At the same time, the subjects' skin roughness was assessed subjectively on a scale from 0 = "unchanged" to 3 = "greatly improved". The results are summarized in Table 1. Examples 1 to 3 are according to the invention, examples V1 to V4 are used for comparison.
Man erkennt, daß die wasserlöslichen ß-Glucane der Erfindung nicht nur den Vorteil der besseren Formulierbarkeit besitzen, sondern zudem auch eine höhere Wirksamkeit als bekannte Glucane des Stands der Technik aufweisen. Tabelle 1:It can be seen that the water-soluble β-glucans of the invention not only have the advantage of being easier to formulate, but also have a higher activity than known glucans of the prior art. Table 1:
Hautalterung und HautrauhigkeitSkin aging and roughness
Figure imgf000013_0001
Figure imgf000013_0001
Legende: 1 ) ß-1 ,3-/ß-1 ,6-Glucan, Extrakt aus Schizophyllum CommuneLegend: 1) ß-1, 3- / ß-1, 6-glucan, extract from Schizophyllum Commune
2) ß-1 ,3-/ß-1 ,4-/ß- 1 ,6-Glucan-Protein (30 %)-Komplex, Extrakt aus Conolossus versicoior2) ß-1, 3- / ß-1, 4- / ß-1, 6-glucan protein (30%) complex, extract from Conolossus versicoior
3) ß-1 ,3-/ ß-1 ,6-Glucan, Extrakt aus Sclereoticum glucanium3) ß-1, 3- / ß-1, 6-glucan, extract from Sclereoticum glucanium
4) Carboxymethyliertes ß-1 ,3-Glucan, Extrakt aus Saccharomyces cervisiae4) Carboxymethylated β-1,3-glucan, extract from Saccharomyces cervisiae
5) α-Mannene mit Verzweigungen, Extrakt aus Saccharomyces cervisiae5) α-Mannes with branches, extract from Saccharomyces cervisiae
6) + 7) ß-1,3/ß-1,4-Glucan + α-1,3-/α-1,4-Glucan-Mischung, Extrakt aus Cetraria isiandica (Flechtenextrakt) 6) + 7) ß-1,3 / ß-1,4-glucan + α-1,3- / α-1,4-glucan mixture, extract from Cetraria isiandica (lichen extract)

Claims

Patentansprüche claims
1. Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung.1. Use of water-soluble ß-glucans as active ingredients for the production of therapeutic agents for skin treatment.
2. Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von Mitteln, die der Hautalterung entgegenwirken.2. Use of water-soluble ß-glucans as active ingredients for the production of agents which counteract skin aging.
3. Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von Sonnenschutzmitteln.3. Use of water-soluble ß-glucans as active ingredients for the production of sunscreens.
4. Verwendung nach den Ansprüchen 1 bis 3, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Extrakte von Basidiomyceten und/oder Ascomyceten einsetzt.4. Use according to claims 1 to 3, characterized in that extracts of Basidiomycetes and / or Ascomycetes are used as water-soluble β-glucans.
5. Verwendung nach den Ansprüchen 1 bis 4, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Extrakte der Pilze Schizophyllum Commune, Conolosus versicoior und/oder Scleroticum glucanium einsetzt.5. Use according to claims 1 to 4, characterized in that extracts of the fungi Schizophyllum Commune, Conolosus versicoior and / or Scleroticum glucanium are used as water-soluble ß-glucans.
6. Verwendung nach den Ansprüchen 1 bis 5, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Schizophyiian und/oder Krestin einsetzt.6. Use according to claims 1 to 5, characterized in that Schizophyiian and / or Krestin are used as water-soluble β-glucans.
7. Verwendung nach den Ansprüchen 1 bis 6, dadurch gekennzeichnet, daß man die ß-Glucane in kosmetischen und/oder pharmazeutischen Zubereitungen einsetzt.7. Use according to claims 1 to 6, characterized in that the ß-glucans are used in cosmetic and / or pharmaceutical preparations.
8. Verwendung nach Anspruch 7, dadurch gekennzeichnet, daß man die ß-Glucane in Mengen von 0,0001 bis 5 Gew.-% - bezogen auf die Mittel - einsetzt. 8. Use according to claim 7, characterized in that one uses the ß-glucans in amounts of 0.0001 to 5 wt .-% - based on the agent.
GEÄNDERTE ANSPRUCHECHANGED CLAIMS
[beim Internationalen Büro am 28.August 1998 (28.08.98) eingegangen; ursprüngliche Ansprüche 1-8 durch; neue Ansprüche 1-7 ersetzt (1 Seite)][Received at the International Office on August 28, 1998 (August 28, 1998); original claims 1-8 by; new claims 1-7 replaced (1 page)]
1. Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von Mitteln, die der Hautalterung entgegenwirken.1. Use of water-soluble ß-glucans as active ingredients for the production of agents that counteract skin aging.
2. Verwendung von wasserlöslichen ß-Glucanen als Wirkstoffe zur Herstellung von Sonnenschutzmitteln.2. Use of water-soluble ß-glucans as active ingredients for the production of sunscreens.
3. Verwendung nach den Ansprüchen 1 bis 3, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Extrakte von Basidiomyceten und/oder Ascomyceten einsetzt.3. Use according to claims 1 to 3, characterized in that extracts of Basidiomycetes and / or Ascomycetes are used as water-soluble β-glucans.
4. Verwendung nach den Ansprüchen 1 bis 4, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Extrakte der Pilze Schizophyllum Commune, Conolosus versicoior und/oder Scleroticum glucanium einsetzt.4. Use according to claims 1 to 4, characterized in that extracts of the fungi Schizophyllum Commune, Conolosus versicoior and / or Scleroticum glucanium are used as water-soluble ß-glucans.
5. Verwendung nach den Ansprüchen 1 bis 5, dadurch gekennzeichnet, daß man als wasserlösliche ß-Glucane Schizophyiian und/oder Krestin einsetzt.5. Use according to claims 1 to 5, characterized in that Schizophyiian and / or Krestin is used as the water-soluble β-glucans.
6. Verwendung nach den Ansprüchen 1 bis 6, dadurch gekennzeichnet, daß man die ß-Glucane in kosmetischen und/oder pharmazeutischen Zubereitungen einsetzt.6. Use according to claims 1 to 6, characterized in that the ß-glucans are used in cosmetic and / or pharmaceutical preparations.
7. Verwendung nach Anspruch 7, dadurch gekennzeichnet, daß man die ß-Glucane in Mengen von 0,0001 bis 5 Gew.-% - bezogen auf die Mittel - einsetzt. 7. Use according to claim 7, characterized in that one uses the ß-glucans in amounts of 0.0001 to 5 wt .-% - based on the agent.
PCT/EP1998/001202 1997-03-13 1998-03-04 THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT WO1998040082A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19710368.5 1997-03-13
DE1997110368 DE19710368A1 (en) 1997-03-13 1997-03-13 Use of water-soluble beta-glucans as active ingredients for the production of therapeutic agents for skin treatment

Publications (1)

Publication Number Publication Date
WO1998040082A1 true WO1998040082A1 (en) 1998-09-17

Family

ID=7823230

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/001202 WO1998040082A1 (en) 1997-03-13 1998-03-04 THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT

Country Status (2)

Country Link
DE (1) DE19710368A1 (en)
WO (1) WO1998040082A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911056A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Cosmetic preparations
DE19911053A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Cosmetic and / or pharmaceutical preparations
DE19911058A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Use of nanoscale water-soluble beta (1,3) glucans
WO2000054742A1 (en) * 1999-03-12 2000-09-21 Biotec Asa USE OF WATER-SOLUBLE β-(1,3) GLUCANS AS AGENTS FOR PRODUCING THERAPEUTIC SKIN TREATMENT AGENTS
DE19911052A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sunscreen
US6251877B1 (en) * 1998-03-24 2001-06-26 Pacific Corporation Composition for external application containing a β-1,6-branched-β-1,3-glucan
US6342486B1 (en) * 1996-07-19 2002-01-29 Mibelle Ag Cosmetics Polymer glucan ether derivatives, their manufacturing as well as their use
WO2003086421A1 (en) * 2002-04-16 2003-10-23 Cac Corporation External preparations for enhancing cell activity
WO2003101460A1 (en) 2002-06-03 2003-12-11 Cac Corporation External preparations for treating dermatitis
KR100543124B1 (en) * 1998-12-30 2006-04-28 주식회사 태평양 Pharmaceutical Composition for Reducting or Preventing Sking Irritation or Sensitization by Drugs
CN112079938A (en) * 2020-08-18 2020-12-15 周银根 Highland barley polysaccharide extraction method, highland barley polysaccharide extract and application thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911057C2 (en) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Hair cosmetic preparations
DE10145008A1 (en) * 2001-09-12 2003-03-27 Odenco Kosmetik Gmbh Cosmetic composition e.g. useful for skin treatment, comprises a ubiquinone or plastoquinone, beta-glucan, Dead Sea water and a solubilizing agent
WO2007001904A2 (en) * 2005-06-21 2007-01-04 The Procter & Gamble Company Personal care compositions comprising alpha-glucans and/or beta-glucans
CN103735566A (en) * 2013-12-26 2014-04-23 南京理工大学 Application of soracan gum in inhibiting skin injury of ultraviolet ray
CN105106032A (en) * 2015-09-10 2015-12-02 南京理工大学 Application of soracan gum in hair washing and caring

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833131A (en) * 1985-08-19 1989-05-23 Bioglucans, L.P. Soluble phosphorylated glucan: methods and compositions for wound healing
JPH03204804A (en) * 1989-12-28 1991-09-06 Mitsui Toatsu Chem Inc Skin cosmetic
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
EP0520112A1 (en) * 1990-02-15 1992-12-30 CAC Corporation Dermatological composition based on an aqueous phase
WO1995022310A1 (en) * 1994-02-18 1995-08-24 Ciba-Geigy Ag Cosmetic compositions
WO1996028476A1 (en) * 1995-03-13 1996-09-19 Novogen Research Ltd. Process for glucan preparation and therapeutic uses of glucan
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19537509A1 (en) * 1995-09-27 1997-04-10 Egsto Pharm Pharmazeutische Pr Prods. for treating irritated skin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833131A (en) * 1985-08-19 1989-05-23 Bioglucans, L.P. Soluble phosphorylated glucan: methods and compositions for wound healing
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
JPH03204804A (en) * 1989-12-28 1991-09-06 Mitsui Toatsu Chem Inc Skin cosmetic
EP0520112A1 (en) * 1990-02-15 1992-12-30 CAC Corporation Dermatological composition based on an aqueous phase
WO1995022310A1 (en) * 1994-02-18 1995-08-24 Ciba-Geigy Ag Cosmetic compositions
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
WO1996028476A1 (en) * 1995-03-13 1996-09-19 Novogen Research Ltd. Process for glucan preparation and therapeutic uses of glucan

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
D. PATON: "Oats: Chemistry, technology and potential uses in the cosmetic industry", COSMET. TOILET., vol. 110, March 1995 (1995-03-01), pages 63 - 70, XP002072530 *
F. ZÜLLI: "Carboxymethylated beta-(1-3)-glucan", COSMET. TOILET., vol. 111, no. 12, 1996, pages 91,92,95-98, XP002072528 *
J. DERMATOL., 21(1), 5-13, 1994 *
J. NAKAYAMA: "Effects of krestin (PSK) on tumorigenesis induced by two-stage and complete chemical carcinogenesis", FILE MEDLINE, STN INTERNATIONAL, KARLSRUHE, AN=94209497, XP002072529 *
P.W.A. MANSELL: "Polysaccharides in skin care", COSMET. TOILET., vol. 109, no. 9, 1994, pages 67,68,70,72, XP002072527 *
PATENT ABSTRACTS OF JAPAN vol. 015, no. 474 (C - 0890) 3 December 1991 (1991-12-03) *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342486B1 (en) * 1996-07-19 2002-01-29 Mibelle Ag Cosmetics Polymer glucan ether derivatives, their manufacturing as well as their use
US6251877B1 (en) * 1998-03-24 2001-06-26 Pacific Corporation Composition for external application containing a β-1,6-branched-β-1,3-glucan
DE19901270B4 (en) * 1998-03-24 2007-09-13 Amorepacific Corp. Process for the liquid cultivation of Schizophyllum commune Fr. for the isolation of β-1,6-branched-β-1,3-glucan
KR100543124B1 (en) * 1998-12-30 2006-04-28 주식회사 태평양 Pharmaceutical Composition for Reducting or Preventing Sking Irritation or Sensitization by Drugs
DE19911058B4 (en) * 1999-03-12 2004-09-30 Biotec Asa Use of nanoscale water-soluble β- (1,3) -glucans
DE19911056B9 (en) * 1999-03-12 2005-09-08 Biotec Asa Cosmetic preparations and their use
WO2000054743A1 (en) * 1999-03-12 2000-09-21 Biotec Asa Cosmetic and/or pharmaceutical preparations
DE19911052A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sunscreen
WO2000054742A1 (en) * 1999-03-12 2000-09-21 Biotec Asa USE OF WATER-SOLUBLE β-(1,3) GLUCANS AS AGENTS FOR PRODUCING THERAPEUTIC SKIN TREATMENT AGENTS
DE19911053A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Cosmetic and / or pharmaceutical preparations
DE19911058A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Use of nanoscale water-soluble beta (1,3) glucans
US6706696B1 (en) 1999-03-12 2004-03-16 Biotec Asa Cosmetic and/or pharmaceutical preparations
DE19911056A1 (en) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Cosmetic preparations
DE19911053B4 (en) * 1999-03-12 2004-10-28 Biotec Asa Cosmetic and / or pharmaceutical preparations
DE19911056B4 (en) * 1999-03-12 2004-11-11 Biotec Asa Cosmetic preparations and their use
WO2000054738A1 (en) * 1999-03-12 2000-09-21 Biotec Asa Cosmetic preparations
US6875754B1 (en) 1999-03-12 2005-04-05 Biotec Asa Use of water-soluble β-(1,3) glucans as agents for producing therapeutic skin treatment agents
WO2003086421A1 (en) * 2002-04-16 2003-10-23 Cac Corporation External preparations for enhancing cell activity
EP1512404A1 (en) * 2002-06-03 2005-03-09 Cac Corporation External preparations for treating dermatitis
EP1512404A4 (en) * 2002-06-03 2006-04-12 Cac Corp External preparations for treating dermatitis
AU2002355005B2 (en) * 2002-06-03 2006-04-13 Cac Corporation External preparations for treating dermatitis
WO2003101460A1 (en) 2002-06-03 2003-12-11 Cac Corporation External preparations for treating dermatitis
US7897161B2 (en) 2002-06-03 2011-03-01 Cac Corporation External medicine for treating dermatitis
CN112079938A (en) * 2020-08-18 2020-12-15 周银根 Highland barley polysaccharide extraction method, highland barley polysaccharide extract and application thereof

Also Published As

Publication number Publication date
DE19710368A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
WO1998040082A1 (en) THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT
DE19623763C2 (en) Cosmetic preparations
WO1997047282A1 (en) Cosmetic and/or pharmaceutical preparations
EP0804280B1 (en) Emulsifying agents
WO2000054742A1 (en) USE OF WATER-SOLUBLE β-(1,3) GLUCANS AS AGENTS FOR PRODUCING THERAPEUTIC SKIN TREATMENT AGENTS
EP1165020B1 (en) Cosmetic preparations
EP0776658A1 (en) Sugartensides and fatty acid partial glycerides containing cosmetical and/or pharmaceutical preparations
DE19716070C2 (en) Sunscreen
DE60132102T2 (en) MELANOGENESIS INHIBITORS AND LIGHTENING AGENTS COMPRISING AN ERGOSTEROL DERIVATIVE AND AN ERGOSTEROL DERIVATIVE COMPOSITIONS
EP0813861A2 (en) Sunscreen compositions in the form of oil-in-water microemulsions
EP0941054B1 (en) Use of sterolsulfates as active substances for producing means to inhibit serin proteases
DE19652302C1 (en) Stable, homogeneous cosmetic skin care preparation
DE19615777C2 (en) Use of lactic acid-lactic acid ester mixtures
EP0784972B1 (en) Cosmetic and/or pharmaceutical emulsions
EP1069884A1 (en) Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids
DE19643062C2 (en) Use of polyol poly-12-hydroxystearates as pigment dispersants
DE19744703C1 (en) Phyto-sterol ester useful as emollient agent in skin and hair care formulation
EP0852138B1 (en) Cosmetic compositions
EP1131040B1 (en) Ethanolic cosmetic preparations containing chitosan
DE19534370C2 (en) Use of cationic chitosan
EP1648394A1 (en) Method for accelerated administration of carotenoid mixtures in serum and tissues
DE19652299C2 (en) Use of ester quats
DE102022203486A1 (en) Use of branched medium-chain glycerol ethers as anti-dandruff active ingredients
DE29520816U1 (en) Cosmetic and / or pharmaceutical emulsions
EP0830857A2 (en) Cosmetic compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998539163

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase